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Beclin-1Mitochondrial aldehyde dehydrogenase 2 (ALDH2) was demonstrated to play cardioprotective roles in
cardiovascular diseases. Nonetheless, little is known about the roles and mechanisms of ALDH2 in pressure
overload-induced cardiac damages. In this study, we revealed that ALDH2 deﬁciency overtly exacerbated trans-
verse aortic constriction (TAC)-induced cardiac dysfunction. Cardiomyocyte enlargement was observed in both
WT and ALDH2−/−mice in HE-stained myocardial tissue samples at 8 weeks post TAC surgery. Mitochondrial
morphology and structurewere also signiﬁcantly damaged post TAC surgery and the changeswere aggravated in
ALDH2−/− TAC hearts. ALDH2 deﬁciency also depressed myocardial autophagy in hearts at 8 weeks post TAC
surgery with a potential mechanism of repressing the expression of Beclin-1 and promoting the interaction be-
tween Bcl-2 and Beclin-1. These data indicate that ALDH2 deﬁciency exacerbates the pressure overload induced
cardiac dysfunction partly by inhibiting Beclin-1 dependent autophagy pathway.
This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Heart failure is a leading cause of mobility and mortality worldwide
and it is the ﬁnal result of many different insults to the myocardium.
Clinical and experimental studies have demonstrated that chronic
excessive pressure overload is a signiﬁcant risk factor for heart failure
and sudden death [1,2]. It is known that the initial growth response to
pressure overload is an important compensatory process and thought
to be beneﬁcial for maintaining the normal heart function. Nonetheless,
continued pressure overload, such as in the case of resistant hyperten-
sion could initiate a series of pathological cardiac remodeling, and even-
tually lead to heart failure [3]. The pathological progress is characterized
by the enlargement of cardiomyocyte size, activation of “fetal gene
program”, cytoskeletal reorganization and irreversible decompensation
of contractile dysfunction [4,5].y and protein quality control in
ovascular Diseases, Zhongshan
University, 180 Fenglin Road,
6 21 64223006.Pathological cardiac hypertrophy is often accompanied with
activation of anabolism and catabolism [6] and the imbalance between
anabolism and catabolism often results in the dysfunction of intracellu-
lar organelles and structural remodeling. Autophagy, an evolutionary
conserved process, plays a crucial role in regulating the degradation
and recycling of damaged protein and intracellular organelles [7]. It
has been shown in the past decades that autophagy dysfunction was
linked with a variety of heart disease models, including ischemia/
reperfusion or ischemic injury, alcoholic cardiomyopathy and diabetic
cardiomyopathy, and pressure overload-induced heart failure [8–11].
However, the precise role of autophagy in the pathological process of
cardiac geometry and function post pressure overload stimulation still
remains controversial [1,8]. Some studies have suggested that augment-
ed autophagy aggravated pathological cardiac hypertrophy and heart
failure, [12,13], while on the contrary other works found that upregula-
tion of autophagy is an adaptive response to pressure overload stress
[14]. Several autophagy related signaling molecules, which actively
participated in the pathological process post pressure overload, have
been identiﬁed now, i.e., the classical AMP-activated protein kinase–
mammalian target of rapamycin pathway (AMPK–mTOR-autophagy),
Beclin-1 dependent pathway and JNK-Foxo3a signaling pathways
[15–17].
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members of the ALDH gene family in humans, has been shown to play
a critical role in the metabolism of acetaldehyde and other toxic
aldehydes such as 4-hydroxy 2-nonenol (4-HNE) [9,18,19]. Evidences
of our researches and others have demonstrated a cardioprotective
role of ALDH2 activation in attenuating ischemic injury, toxic damage
and alcoholic cardiomyopathy [18,20,21]. Interestingly, autophagy has
proved to be indispensable in the above-mentioned injuries [18,20,
21]. Furthermore, the prevalence of hypertension and related pressure
overload injuries has been steadily increasing worldwide now. It isFig. 1. Effect of ALDH2 deﬁciency on pressure overload-induced LV dysfunction. Quantitative an
tional shortening (LVFS; C), left ventricular end-systolic diameter (LVESD; D), left ventricula
(LVPWD; F). Mean ± SEM, *P b 0.05 vs. WT Sham group, #P b 0.05 vs. WT TAC group, +P b 0.0known that approximately half the Asian population is carrying one
copy of the mutant ALDH2 gene [22]. The interaction between hyper-
tension and ALDH2 genotype remains unknown now. We speculate
that ALDH2might also play an important role in the process of pressure
overload-induced heart failure via regulating autophagy.
Thus, this study was designed to elucidate the role of ALDH2 on
pressure overload injury and related mechanisms focusing on
autophagy. Changes of cardiac function and autophagy signalingwere ex-
amined inwild-type (WT) andALDH2knockout (ALDH2−/−)micewith
or without the transverse aortic constriction (TAC) surgery.alysis of heart rate (HR; A), left ventricular ejection fraction (LVEF; B), left ventricular frac-
r end-diastolic diameter (LVEDD; E), left ventricular diastole posterior wall dimension
5 vs. ALDH2−/− sham group.
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2.1. Experimental animals and TAC surgery
All animal procedures described in this study were approved by
the Animal Care and Use Committee of Fudan University and the sur-
gery procedure was in compliance with the guidelines of “the Guide
for the Care and Use of Laboratory Animals” Academy Press (NIH
Publication No. 85–23, revised 1996). Adult male WT mice (C57BL/
6, 8 weeks old, weighing 22–25 g) were bought from the Shanghai
Animal Administration Center (Shanghai, China). ALDH2−/− mice
were produced by method described previously [22]. The TAC
model was used to generate pressure overload-induced hypertrophy
and heart failure. Animals were randomly assigned to sham or TAC
group and observed at 8 weeks post surgery. In brief, mice were
anesthetized with isoﬂurane and were placed in a supine position.
The chest was opened and the transverse aortic was dissected free
at the aortic arch level of surrounding tissues and muscles. A 5-0
nylon suture was tied around the aorta and a blunted 27-gauge
needle which was removed after the ligation. The sham group
underwent all operation procedures apart from the ligation. Mice
were housed at room temperature under a 12-hour light/dark cycle
with free access to water and standard laboratory mouse chow.
2.2. Echocardiographic assessment
Transthoracic echocardiography was performed using a 30-MHz
high-frequency scan head as previously described (VisualSonics
Vevo770; VisualSonics Inc. Toronto, Canada) to evaluate cardiac
geometry and function. Left ventricular (LV) parasternal long-axisFig. 2.Hypertrophic and histological characteristics inWT and ALDH2−/−mice with or witho
to-body weight ratio (LW/BW; B). Representative images of hematoxylin and eosin (HE)-stain
WT sham group (D), WT TAC group (E), ALDH2−/− sham group (F), ALDH2−/− TAC group (
bar, 20 μm. Mean ± SEM, *P b 0.05 vs. WT sham group, #P b 0.05 vs. WT TAC group, +P b 0.05view was recorded. All the data were averaged measurements of at
least 5 cardiac cycles of everymice inM-mode, including left ventricular
ejection fraction (LVEF) and left ventricular fractional shortening
(LVFS), left ventricular end-systolic diameter (LVESD), left ventricular
end-diasolic diameter (LVEDD) and left ventricular diastole posterior
wall dimension (LVPWD).
2.3. Histological analysis
Theheartwas arrested after anesthesia by ketamine (intraperitoneal
injection, i.p. 50 mg/kg). Heart weight and lung wet weight were mea-
sured. For histological analysis, heart tissues were ﬁxed in 4% neutral
formaldehyde at room temperature for more than 24 h. The specimen
was embedded in parafﬁn and serial sections were cut at 4 μm in the
short axis at the papillary muscle lever, and stained with hematoxylin
and eosin (HE) to analyze the cardiomyocyte morphology and cross-
sectional areas. Cardiomyocytes with clear myoﬁber outlines and inte-
gral nucleus were measured to analyze the cross-sectional area (CSA)
on a high-resolution digital microscope (×400) by the image analysis
system (QwinV3, Leica, Wetzlar, Germany). The cross-sectional area of
cardiomyocytes was quantiﬁed from 3 slices of each heart, 5 high
power random ﬁelds from each section, results were averaged.
2.4. Transmission electron microscopy (TEM)
Left ventricular tissues were dissected into small cubic pieces ≦1
mm3 and ﬁxed with 2.5% glutaraldehyde (pH 7.4) for more than 2 h.
After being washed in 0.1 M phosphate buffer (PB) for 3 times, the tis-
sueswere ﬁxed in 1% osmium tetroxide. Then sampleswere dehydrated
by graded ethanol with the last dehydrated procedure in 90% acetone.ut TAC surgery. Quantitative analysis of heart-to-bodyweight ratio (HW/BW; A) and lung-
ing displaying transverse myocardial sections of left ventricular myocardium (×400) from
G). C, Quantitative analysis of cardiomyocyte cross section areas (CSA) in each group. Scale
vs. ALDH2−/− sham group.
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Araldite and ﬁxed, ultrathin sections (50–60 nm) were cut using an
LKB-I ultramicrotome (Leika, Germany) and stained with 3% uranyl ac-
etate and lead citrate. Images were captured with the CM-120
transmission electron microscope (Philip, Holland).
2.5. Western blot analysis
Hearts were quickly-frozen in liquid nitrogen and stored at−80 °C.
Procedures of protein extraction and Western blot were carried out as
described previously [11]. Polyclonal rabbit antibodies against phos-
phorylated AMPKα (pAMPKα) at Thr172 (2535S), total AMPKα
(2532S), Beclin-1 (3738S), p62 (5114S), LC3B (3868S), phosphorylated
mTOR at Ser2448 (5536S), total mTOR (2983S; 1:1000; Rabbit; Cell
Signaling Technology Inc. Boston, USA); ALDH2 (1:1000; Rabbit; Santa
Cruz Biotechnology Inc. Dallas, USA) and horseradish peroxidase-
conjugated secondary antibody (KANGCHEN Biotechnology, Nanjing,
China) were examined by standard Western blotting. Respective
proteins were analyzed with GAPDH serving as the loading control.
2.6. Co-immunoprecipitation
The co-immunoprecipitation (Co-IP) assay was performed as previ-
ously reported [23]. Brieﬂy, protein was ﬁrstly incubated with Protein
A/G PLUS-Agorase Immunoprecipitation Reagant (Santa Cruz, sc-2003)
and certain amount of supernatant (500 μg protein) was transferred to
a tube. Beclin-1 primary antibody (1:50) and 20 μl resuspended agarose
were added to the tube and themixturewas incubated at 4 °C on a rocker
platform overnight. After being washed with lysate, the agarose wasFig. 3.Ultrastructural changes in left ventricularmyocardium fromWTandALDH2−/−micewi
of left ventricular fromWT shamgroup (A),WT TAC group (B), ALDH2−/− shamgroup (C), ALD
(white arrows) are presented in the ﬁgure. Scale bar, 2 μm.eluted with SDS/PAGE loading buffer and then subjected to SDS/PAGE
and Western blotting.
2.7. Statistical analysis
Data were presented as mean ± SEM. Multi-group comparison was
performed by one-way ANOVA followed by a Tukey's test for post hoc
analysis. Analysis was performed with GraphPad Prism 5.0 software
(GraphPad, San Diego, CA). A value of P b 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. ALDH2 deﬁciency exacerbates pressure overload-induced cardiac
dysfunction in mice
Echocardiographic examination was performed at 8 weeks post TAC
or sham surgery. Increased LVESD, decreased LVEF and LVFS were found
while LVEDD remained unchanged in WT mice post TAC surgery.
Although ALDH2 deﬁciency failed to affect any of the echocardiographic
parameters measured in the absence of pressure overload exposure, it
exacerbated these effects and increased LVEDD after TAC surgery
(Fig. 1B–E). Besides, LVPWD in WT TAC mice was much thicker than in
the WT sham group, while it was reversed to be much thinner in
ALDH2−/− TAC mice (Fig. 1F). In addition, the heart-to-body weight
ratio (HW/BW) was signiﬁcantly increased in WT mice at 8 weeks post
TAC surgery, however, this effect disappeared in ALDH2−/− TAC mice
(Fig. 2A), which was more or less consistent with the echocardiographic
result of LVPWD. The lung-to-body weight ratio (LW/BW) wasth orwithout TAC surgery. Representative transmission electronmicroscopy (TEM) images
H2−/− TAC group (D). Normalmitochondria (black arrows) and damagedmitochondria
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lenge (Fig. 2B). These results suggest that ALDH2 depletion accentuates
pressure overload-induced contractile dysfunction and cardiac
remodeling.
3.2. ALDH2 Deﬁciency augments histological changes induced by pressure
overload in mice
To evaluate the pressure overload-induced structural changes inWT
and ALDH2−/−mice, myocardial histology was evaluated. HE staining
showed that TAC surgery did not affect the arrangement and structure
of cardiomyocytes (Fig. 2D–G), however, similarly increased CSA was
obtained (Fig. 2C) both in WT and ALDH2−/− mice at 8 weeks post
TAC surgery.
As pressure overload-induced heart injury is often accompanied by
mitochondrial damage [24], TEM was conducted to analyze the changes
of mitochondrial morphology. In the absence of TAC challenge, no
difference was found in myocardial ultrastructure between WT and
ALDH2−/−mice, and the mitochondria were arranged normally in the
organized sarcomeres (black arrows in Fig. 3A and C). However, swelling
changes and disorganized cristae were evidenced in mitochondria of theFig. 4.Effect of ALDH2 deﬁciency on pressure overload-induced changes inmyocardial autophag
speciﬁc antibodies. B, ALDH2 expression. C, LC3B I expression. D, LC3B II expression. E, LC3B II-to
group, +P b 0.05 vs ALDH2−/− sham group.WT-TAC mice (white arrows in Fig. 3B). More aggravated changes were
observed in ALDH2−/− TAC mice, characterized by much larger mito-
chondria, vacuolar changes and disintegrate cristae (white arrows in
Fig. 3D). These observations indicate that ALDH2 deﬁciency exacerbates
pressure overload-induced mitochondrial injury.3.3. ALDH2 deﬁciency exacerbates pressure overload‐ induced inhibition of
autophagy in mice
Our results showed that ALDH2 protein expression was remarkably
reduced in response to pressure overload (Fig.4A and B). Recent studies
suggested a role of autophagy in pressure overload induced cardiac
injury [15,25]. Our data depicted that pressure overload signiﬁcantly
suppressed myocardial autophagy (LC3II-to-LC3I ratio) without affect-
ing autophagy ﬂux (evidenced by invariant autophagy adaptor protein
p62). ALDH2 itself did not affect myocardial autophagy, however, it ac-
centuated pressure overload-induced inhibition of autophagy (Fig. 4A
and C–F). These data suggest that autophagy inhibition is linked with
aggravated pressure overload-induced cardiac dysfunction andmyocar-
dial injury in ALDH2−/−mice.y. A, Representative gel blots of p62, LC3BI/II, ALDH2 andGAPDH (as loading control) using
-I tatio. F, p62 expression. Mean± SEM, *P b 0.05 vsWT sham group, #P b 0.05 vsWT TAC
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expression and promotes the interaction between Bcl-2 and Beclin-1
To further analyze a potential signaling pathway involved in
pressure overload and/or ALDH2 deﬁciency-elicited cardiac autophagic
response, Beclin-1 dependent autophagy pathwaywas examined in our
study. As shown in Fig. 5A and C, dampened expression of Beclin-1 was
found in WT-TAC mice while it was much lower in ALDH2−/− TAC
mice. Beclin-1 (a BH3-only protein) binds to the BH3 domain of Bcl-2
and enhanced interaction between them would restrain autophagy
[26,27]. To examine the interaction of the complex, immunoprecipita-
tionwas performed inWT and ALDH2−/−mice heartswith orwithout
pressure overload challenge. As shown in Fig. 5B andD, ALDH2deﬁcien-
cy itself did not affect the Bcl-2-to-Beclin-1 ratio, but it promoted the in-
teraction between Bcl-2 and Beclin-1 after TAC surgery. These data favor
the notion that ALDH2 deﬁciency accentuates pressure overload-
inhibited autophagy via suppressingBeclin-1 expression andpromoting
the interaction of Bcl-2 and Beclin-1.3.5. ALDH2 deﬁciency accentuates pressure overload-activated AMPK–mTOR
pathway
To explore the potential role of mTOR, a key regulator of autophagy,
in pressure overload-induced cardiac remodeling, phosphorylated
mTOR and its upstream signaling regulator AMPK were examined. Our
results indicated that pressure overload markedly activated the
phosphorylation of AMPK at Thr172 and depressed the phosphorylation
of mTOR at Ser2448 without affecting AMPK and mTOR expression. Al-
though ALDH2 deﬁciency itself did not affect the phosphorylation of
these two molecules, it signiﬁcantly accentuated pressure overload-
induced changes in the phosphorylation of AMPK and mTOR (Fig. 6).
Besides, AMPK could be activated following declined supplements of
energy and metabolic disorder, which was an important pathological
mechanism in pressure overload-induced heart failure [28–30]. These
ﬁndings suggest that ALDH2 deﬁciency could inhibit pressure overload
induced AMPK–mTOR pathway activation and this mechanism might
associate with inadequate energy supplement in case of pressure
overload.Fig. 5. Effect of ALDH2 deﬁciency on pressure overload-induced changes in Beclin-1 and intera
control). C, Beclin-1 expression. B, Representative gel blots of Bcl-2 and Beclin-1 using speciﬁc
SEM, *P b 0.05 vs WT sham group, #P b 0.05 vs WT TAC group, +P b 0.05 vs ALDH2−/− sham4. Discussion
Our results suggested that pressure overload-induced cardiac anom-
alies were exacerbated by ALDH2 deﬁciency and pressure overload also
dampened Beclin-1 dependent autophagy signaling, these effects were
ampliﬁed by ALDH2 deﬁciency. Furthermore, we found that ALDH2
deﬁciency promoted the interaction of Beclin-1 and Bcl-2 post TAC sur-
gery. Although evidence is accumulating that ALDH2 depicted a beneﬁ-
cial role against alcohol, acetaldehyde and toxic aldehyde-induced
cardiac injury [2,9], data from present study represented another
possible protective effect of ALDH2which was capable of counteracting
pressure overload induced myocardial injury.
Cardiac remodeling is characterized by increased cardiomyocyte size
at the early stage of pressure overload, while contractile dysfunction
and dilated cardiomyopathy often represent end-stage heart failure
after sustained pathological stress [31,32]. In our hands, both WT mice
and ALDH2−/−mice developed overt contractile dysfunction as evi-
denced by reduced LVEF, and LVFS and increased LVESD at 8 weeks
post pressure overload challenge. Combinedwith hypertrophic ﬁndings
on LVPWD, HW/BW and CSA,WT-TACmice presented in a maladaptive
functional stage accompanied with adaptive geometric responses.
These results are consistentwith former report showing dampened car-
diomyocyte contractile function in hypertrophic mice [33]. However,
ALDH2−/− TAC mice were already in functional and geometric mal-
adaptive stages, as evidenced by increased LW/BW and much thinner
wall thickness (Fig. 1F). Our results showed that pressure overload
stimulation similarly increased CSA both in WT and ALDH2−/−mice.
The discrepancy between HW/BW and CSA could be explained by the
possibility that functional changes might occur prior to themorpholog-
ical responses during the progression from hypertrophy to heart failure.
In addition, the extracellularmatrix (ECM) remodelingmay partially ac-
count for it duringprogressive cardiac dysfunction [34], as characterized
by imbalance between ECM degradation and accumulation. Since more
serious cardiac dysfunctionwas found in ALDH2−/−mice subjected to
pressure overload, we speculate that this result might partly be related
to the more drastically ECM degradation in ALDH2−/− TACmice com-
pared to that in WT TAC mice. Moreover, pressure overload challenge
signiﬁcantly reduced the myocardial expression of ALDH2. Taken
together, ALDH2 deﬁciency deﬁnitely accelerates the pathologicalction of Bcl-2 and Beclin-1. A, Representative gel blots of Beclin-1 and GAPDH (as loading
antibodies. IP, immunoprecipitation; IB, immunoblot. D, Bcl-2-to-Beclin-1 Ratio. Mean ±
group.
Fig. 6.Western blot analysis exhibiting phosphorylation of AMPK and mTOR in myocardium fromWT and ALDH2−/−mice with or without TAC surgery. A, Representative gel blots
depicting levels of total and phosphorylated AMP-activated protein kinase (AMPK, A) and mammalian target of rapamycin (mTOR, B) and GAPDH (as loading control). C, Total AMPK
expression. D, Total mTOR expression. E, AMPK phosphorylation expression (Thr172, pAMPK-to-AMPK ratio). F, mTOR phosphorylation expression (Ser2448, pmTOR-to-mTOR ratio).
Mean ± SEM, *P b 0.05 vs WT sham group, #P b 0.05 vs WT TAC group, +P b 0.05 vs ALDH2−/− sham group.
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indispensable in pressure overload-induced heart failure.
Our data showed that autophagy was inhibited in the remodeling
hearts post pressure overload, in otherwords, autophagywasdetrimen-
tal to cardiac function under pressure overload. Increasing evidence
has depicted certain range of autophagy was essential to cardiac geom-
etry and function under stress conditions, including hypertrophy,
ischemia/reperfusion, and pressure overload-induced heart failure
[1,8]. Since autophagy activation is needed to promote cell survival by
degradation and turnover of damaged organelles in case of various dis-
ease conditions [1], it is reasonable to speculate the negative effects of
autophagy inhibition in TACmice. Although autophagy is well accepted
to be a critical mediator under hemodynamic stress, it remains contro-
versy with regard to its precise effect in this situation. Some studies
have reported that autophagic activity was overt induced post pressure
overload stress and the ampliﬁed autophagic response was associated
with severe pathological remodeling [17,35,36]. Nonetheless, other
researchers have indicated that autophagic suppression accentuated
hemodynamic stress-induced cardiac hypertrophy and dysfunction [1,
14]. Possible explanations for the observed discrepancies could be the
inhomogeneity of different experimental settings and intervention
periods. Intriguingly, the dual characteristics of autophagy have also
been shown in other organ system and diseases [37]. Data from our
group revealed that ALDH2 deﬁciency exacerbated the decline of au-
tophagy after TAC surgery, which was in parallel with worse cardiacfunction in ALDH2−/− TACmice. Besides, p62 expression, an autopha-
gy adaptor (as evidenced by autophagic ﬂux), remained unchanged
among various groups, suggesting that neither pressure overload nor
ALDH2 deﬁciency affected autolysosome fusion.
Previous studies demonstrate that Beclin-1, a platform protein that
interacts with several different proteins, including a complex with
class III PI3K and Bcl-2, plays an important role in the autophagosome
formation [26,38,39]. Alterations of Bcl-2 expression or phosphorylation
could reﬂect changes on the interaction of Bcl-2/Beclin-1 complex, thus,
affect the autophagy regulation process. Our study revealed that ALDH2
deﬁciency exacerbated pressure overload-induced suppression of au-
tophagy as shown by inhibited Beclin-1. Although pressure overload
did not inhibit the amount of Bcl-2 that immunoprecipitated with
Beclin-1 in WT mice, the ratio of Bcl-2-to-Beclin-1 was signiﬁcantly
increased in ALDH2-/- TACmice. In other words, ALDH2 deﬁciency pro-
moted the interaction of Bcl-2 and Beclin-1 under pressure overload
challenge, which was in parallel with the further depressed myocardial
autophagy. Taken together, our data suggested that dampened Beclin-
1-autophagy cascade in response to pressure overload under ALDH2de-
ﬁciency, leading to exacerbated cardiac geometric and functional
anomalies.
Moreover, upregulated AMPK-mTOR pathway was shown in mice at
8 weeks post TAC surgery, theoretically, these will increase the expres-
sion of LC3B II according to the mTOR-dependent autophagy pathway
[15]. However, it was disaccord with our current results on autophagic
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global coordinator of the metabolic stress response, can be activated fol-
lowing declined supplement of ATP, which serves as another pathological
mechanism of pressure overload injury [30]. Accordingly, metabolism
abnormalitiesmight be apromoter of AMPK-mTORpathwaywithout reg-
ulating autophagy or its effectwas covered by dampened Beclin-1 depen-
dent autophagy pathway. In parallel, more severe damages of the
mitochondria in ALDH2−/− TAC mice (as shown in Fig. 3) could be
induced by the excessive activation of AMPK–mTOR pathway. Further
work is needed to deﬁne the accurate inﬂuence or interaction between
the two pathways in pathological cardiac remodeling.
Former studies have demonstrated ALDH2was capable ofmitigating
cardiac remodeling and contractile dysfunction in alcoholic cardiomy-
opathy [40]. Clinical researches have also certiﬁed that ALDH2 gene
polymorphism contribute to the early onset alcoholism [41]. Our data
showed that ALDH2 deﬁciency exacerbated pressure overload-
induced hypertrophy and cardiac dysfunction in mice. This ﬁnding is
in line with previous clinical studies in that ALDH2 polymorphism was
closely associated with hypertension [42,43]. However, convincing
clinical and experimental studies on interaction between ALDH2 gene
polymorphisms and heart function following chronic pressure overload
are still lacking. Further clinical studies are warranted to explore the as-
sociation between ALDH2 gene and pressure overload-induced cardio-
myopathy. Since half the of Asian populations carrying one copy of the
mutant ALDH2 gene [22], based on our ﬁnding, they might suffer
more severe disease consequences in case of hypertension, future stud-
ies are warranted to verify the impact of ALDH2 genotype between
Asian and western hypertensive patients.
LW/BW ratio was signiﬁcantly increased in ALDH2−/− mice at
8 weeks post TAC. Two factors might be responsible for this ﬁnding.
First of all, ALDH2−/−mice were compelling in more serious stage ofFig. 7. Schematic diagram depicting the role of ALDH2 in pressure overload-induced
changes in autophagy and cardiac function. Pressure overload suppresses expression of
myocardium ALDH2, which participates in pressure overload-induced inhibition of
Beclin-1 and in promoting the interaction of Bcl-2 and Beclin-1. Besides, ALDH2 also
take part in the activation of AMPK–mTOR pathway possibly induced by energy deﬁcien-
cy. The Beclin-1 dependent pathway plays a key role in pressure overload-induced
inhibition of autophagy, leading to heart failure. Arrows denote stimulation whereas the
lines with a “T” ending represent inhibition.cardiac dysfunction as evidenced by signiﬁcantly reduced LVEF, LVFS
and increased LVESD. On the other hand, the limited absorptivity of
gauze which we used to absorb the lung surface liquid might also con-
tribute to the observed the high LW/BW ratio in ALDH2−/− mice at
8 weeks post TAC.
5. Conclusion
In summary, our results suggest that ALDH2 deﬁciency exacerbated
pressure overload-induced cardiac dysfunction, possibly through sup-
pression of Beclin-1 dependent autophagy pathway (Fig. 7). Restoration
of autophagy functionmay thus be an approach to attenuate cardiac geo-
metric and functional abnormalities in ALDH2−/−mice after pressure
overload. Our ﬁndings further suggest that individuals carrying low levels
or mutated ALDH2 alleles are prone to cardiac dysfunction under chronic
hemodynamic stress such as hypertension and activating autophagy
might serve as a potential therapeutic strategy in the population.
Conﬂict of interests
All authors declare no conﬂict of interest.
Acknowledgements
This study was supported by a grant to Aijun Sun from the program
for New Century Excellent Talents (NCET-12-0125).
References
[1] B.A. Rothermel, J.A. Hill, Autophagy in load-induced heart disease, Circ. Res. 103
(2008) 1363–1369.
[2] S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, V. Polyakova, E.P. Bauer, W.P.
Klovekorn, J. Schaper, Progression from compensated hypertrophy to failure in the
pressure-overloaded human heart: structural deterioration and compensatory
mechanisms, Circulation 107 (2003) 984–991.
[3] D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, K.K. Ho, The progression from hyper-
tension to congestive heart failure, JAMA 275 (1996) 1557–1562.
[4] B.H. Lorell, B.A. Carabello, Left ventricular hypertrophy: pathogenesis, detection, and
prognosis, Circulation 102 (2000) 470–479.
[5] G.N. Dorn, The fuzzy logic of physiological cardiac hypertrophy, Hypertension 49
(2007) 962–970.
[6] E.D. Frohlich, D. Susic, Pressure overload, Heart Fail. Clin. 8 (2012) 21–32.
[7] X. Qu, Z. Zou, Q. Sun, K. Luby-Phelps, P. Cheng, R.N. Hogan, C. Gilpin, B. Levine,
Autophagy gene-dependent clearance of apoptotic cells during embryonic develop-
ment, Cell 128 (2007) 931–946.
[8] A. Nemchenko, M. Chiong, A. Turer, S. Lavandero, J.A. Hill, Autophagy as a therapeu-
tic target in cardiovascular disease, J. Mol. Cell. Cardiol. 51 (2011) 584–593.
[9] H. Ma, R. Guo, L. Yu, Y. Zhang, J. Ren, Aldehyde dehydrogenase 2 (ALDH2) rescues
myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic
aldehyde, Eur. Heart J. 32 (2011) 1025–1038.
[10] R. Guo, J. Ren, Deﬁciency in AMPK attenuates ethanol-induced cardiac contractile
dysfunction through inhibition of autophagosome formation, Cardiovasc. Res. 94
(2012) 480–491.
[11] X. Xu, Y. Hua, S. Nair, R. Bucala, J. Ren, Macrophage migration inhibitory factor dele-
tion exacerbates pressure overload-induced cardiac hypertrophy through mitigat-
ing autophagy, Hypertension 63 (2014) 490–499.
[12] H. Zhu, P. Tannous, J.L. Johnstone, Y. Kong, J.M. Shelton, J.A. Richardson, Cardiac au-
tophagy is a maladaptive response to hemodynamic stress, J. Clin. Invest. 117
(2007) 1782–1793.
[13] D.J. Cao, Z.V. Wang, P.K. Battiprolu, N. Jiang, C.R. Morales, Y. Kong, B.A. Rothermel, T.
G. Gillette, J.A. Hill, Histone deacetylase (HDAC) inhibitors attenuate cardiac
hypertrophy by suppressing autophagy, Proc. Natl. Acad. Sci. U. S. A. 108 (2011)
4123–4128.
[14] A. Nakai, O. Yamaguchi, T. Takeda, Y. Higuchi, S. Hikoso, M. Taniike, S. Omiya, I.
Mizote, Y. Matsumura, M. Asahi, K. Nishida, M. Hori, N. Mizushima, K. Otsu, The
role of autophagy in cardiomyocytes in the basal state and in response to hemody-
namic stress, Nat. Med. 13 (2007) 619–624.
[15] S. Sciarretta, M. Volpe, J. Sadoshima, Mammalian target of rapamycin signaling in
cardiac physiology and disease, Circ. Res. 114 (2014) 549–564.
[16] H. Lin, H.F. Li, H.H. Chen, P.F. Lai, S.H. Juan, J.J. Chen, C.F. Cheng, Activating transcrip-
tion factor 3 protects against pressure-overload heart failure via the autophagy
molecule beclin-1 pathway, Mol. Pharmacol. 85 (2014) 682–691.
[17] A.H. Chaanine, D. Jeong, L. Liang, E.R. Chemaly, K. Fish, R.E. Gordon, R.J. Hajjar, JNK
modulates FOXO3a for the expression of the mitochondrial death and mitophagy
marker BNIP3 in pathological hypertrophy and in heart failure, Cell Death Dis. 3
(2012) 265.
318 C. Shen et al. / Biochimica et Biophysica Acta 1852 (2015) 310–318[18] A. Sun, Y. Cheng, Y. Zhang, Q. Zhang, S. Wang, S. Tian, Y. Zou, K. Hu, J. Ren, J. Ge, Al-
dehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction
through detoxiﬁcation of 4-HNE and suppression of autophagy, J. Mol. Cell. Cardiol.
71 (2014) 92–104.
[19] J. Liao, A. Sun, Y. Xie, T. Isse, T. Kawamoto, Y. Zou, J. Ge, Aldehyde dehydrogenase-2
deﬁciency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress
induction, Mol. Med. 18 (2012) 785–793.
[20] Y. Zhang, J. Ren, Autophagy in ALDH2-elicited cardioprotection against ischemic
heart disease: slayer or savior? Autophagy 6 (2010) 1212–1213.
[21] W. Ge, J. Ren, mTOR-STAT3-notch signalling contributes to ALDH2-induced protec-
tion against cardiac contractile dysfunction and autophagy under alcoholism, J. Cell.
Mol. Med. 16 (2012) 616–626.
[22] F. Xu, Y. Chen, R. Lv, H. Zhang, H. Tian, Y. Bian, J. Feng, Y. Sun, R. Li, R.Wang, Y. Zhang,
ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD
patients, Hypertens. Res. 33 (2010) 49–55.
[23] S. Wang, A. Sun, L. Li, G. Zhao, J. Jia, K. Wang, J. Ge, Y. Zou, Up-regulation of BMP-2
antagonizes TGF-beta1/ROCK-enhanced cardiac ﬁbrotic signalling through activa-
tion of Smurf1/Smad6 complex, J. Cell. Mol. Med. 16 (2012) 2301–2310.
[24] H. Bugger, M. Schwarzer, D. Chen, A. Schrepper, P.A. Amorim,M. Schoepe, T.D. Nguyen,
F.W. Mohr, O. Khalimonchuk, B.C. Weimer, T. Doenst, Proteomic remodelling of mito-
chondrial oxidative pathways in pressure overload-induced heart failure, Cardiovasc.
Res. 85 (2010) 376–384.
[25] G. Marino, F. Pietrocola, Y. Kong, T. Eisenberg, J.A. Hill, F. Madeo, G. Kroemer,
Dimethyl alpha-ketoglutarate inhibits maladaptive autophagy in pressure
overload-induced cardiomyopathy, Autophagy 10 (2014) 930–932.
[26] Y. Maejima, S. Kyoi, P. Zhai, T. Liu, H. Li, A. Ivessa, S. Sciarretta, R.D. Del, D.K. Zablocki,
C.P. Hsu, D.S. Lim, M. Isobe, J. Sadoshima, Mst1 inhibits autophagy by promoting the
interaction between beclin1 and Bcl-2, Nat. Med. 19 (2013) 1478–1488.
[27] R.T. Marquez, L. Xu, Bcl-2:beclin 1 complex: multiple, mechanisms regulating
autophagy/apoptosis toggle switch, Am. J. Cancer Res. 2 (2012) 214–221.
[28] N.B. Ruderman, D. Carling, M. Prentki, J.M. Cacicedo, AMPK, insulin resistance, and
the metabolic syndrome, J. Clin. Invest. 123 (2013) 2764–2772.
[29] L. Garcia-Menendez, G. Karamanlidis, S. Kolwicz, R. Tian, Substrain speciﬁc response
to cardiac pressure overload in C57BL/6 mice, Am. J. Physiol. Heart Circ. Physiol. 305
(2013) H397–H402.
[30] F. Heidrich, H. Schotola, A.F. Popov, C. Sohns, J. Schuenemann, M. Friedrich, K.O.
Coskun, D. von Lewinski, J. Hinz, M. Bauer, S.A. Mokashi, S. Sossalla, J.D. Schmitto,
AMPK — activated protein kinase and its role in energy metabolism of the heart,
Curr. Cardiol. Rev. 6 (2010) 337–342.[31] Y. Hua, Y. Zhang, J. Ren, IGF-1 deﬁciency resists cardiac hypertrophy and myocardial
contractile dysfunction: role of microRNA-1 and microRNA-133a, J. Cell. Mol. Med.
16 (2012) 83–95.
[32] J.J. Hunter, K.R. Chien, Signaling pathways for cardiac hypertrophy and failure, N.
Engl. J. Med. 341 (1999) 1276–1283.
[33] Y. Takeishi, P. Ping, R. Bolli, D.L. Kirkpatrick, B.D. Hoit, R.A.Walsh, Transgenic overex-
pression of constitutively active protein kinase C epsilon causes concentric cardiac
hypertrophy, Circ. Res. 86 (2000) 1218–1223.
[34] K.R. Hutchinson, J.J. Stewart, P.A. Lucchesi, Extracellular matrix remodeling during
the progression of volume overload-induced heart failure, J. Mol. Cell. Cardiol. 48
(2010) 564–569.
[35] Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, T. Asano, B. Levine, J. Sadoshima,
Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy, Circ. Res. 100
(2007) 914–922.
[36] A.B. Gustafsson, R.A. Gottlieb, Recycle or die: the role of autophagy in cardioprotection, J.
Mol. Cell. Cardiol. 44 (2008) 654–661.
[37] B. Levine, G. Kroemer, Autophagy in the pathogenesis of disease, Cell 132 (2008)
27–42.
[38] X.H. Liang, L.K. Kleeman, H.H. Jiang, G. Gordon, J.E. Goldman, G. Berry, B. Herman, B.
Levine, Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-
interacting protein, J. Virol. 72 (1998) 8586–8596.
[39] S. Jiang, R. Guo, Y. Zhang, Y. Zou, J. Ren, Heavy metal scavenger metallothionein miti-
gates deep hypothermia-inducedmyocardial contractile anomalies: role of autophagy,
Am. J. Physiol. Endocrinol. Metab. 304 (2013) E74–E86.
[40] Y. Zhang, J. Ren, ALDH2 in alcoholic heart diseases: molecular mechanism and
clinical implications, Pharmacol. Ther. 132 (2011) 86–95.
[41] D. Russo, V. Purohit, L. Foudin, M. Salin, Workshop on alcohol use and health
disparities 2002: a call to arms, Alcohol 32 (2004) 37–43.
[42] Y.C. Chang, Y.F. Chiu, I.T. Lee, L.T. Ho, Y.J. Hung, C.A. Hsiung, T. Quertermous, T.
Donlon, W.J. Lee, P.C. Lee, C.H. Chen, D. Mochly-Rosen, L.M. Chuang, Common
ALDH2 genetic variants predict development of hypertension in the SAPPHIRe
prospective cohort: gene-environmental interaction with alcohol consumption,
BMC Cardiovasc. Disord. 12 (2012) 58.
[43] K. Amamoto, T. Okamura, S. Tamaki, Y. Kita, Y. Tsujita, T. Kadowaki, Y. Nakamura, H.
Ueshima, Epidemiologic study of the association of low-Kmmitochondrial acetalde-
hyde dehydrogenase genotypes with blood pressure level and the prevalence of
hypertension in a general population, Hypertens. Res. 25 (2002) 857–864.
